171 related articles for article (PubMed ID: 26579828)
1. Antiretroviral Therapy Fails to Restore Levels of HIV-1 Restriction miRNAs in PBMCs of HIV-1-infected MSM.
Liu MQ; Zhao M; Kong WH; Peng JS; Wang F; Qiu HY; Zhu ZR; Tang L; Sang M; Wu JG; Ho WZ; Zhou W
Medicine (Baltimore); 2015 Nov; 94(46):e2116. PubMed ID: 26579828
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Ghosn J; Leruez-Ville M; Blanche J; Delobelle A; Beaudoux C; Mascard L; Lecuyer H; Canestri A; Landman R; Zucman D; Ponscarme D; Rami A; Viard JP; Spire B; Rouzioux C; Costagliola D; Suzan-Monti M;
Clin Infect Dis; 2014 Jun; 58(12):1763-70. PubMed ID: 24647014
[TBL] [Abstract][Full Text] [Related]
3. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
4. HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy.
Finney CA; Ayi K; Wasmuth JD; Sheth PM; Kaul R; Loutfy MR; Kain KC; Serghides L
AIDS; 2013 Jan; 27(3):325-35. PubMed ID: 23291537
[TBL] [Abstract][Full Text] [Related]
5. Plasma microRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy.
Marquez-Pedroza J; Cárdenas-Bedoya J; Morán-Moguel MC; Escoto-Delgadillo M; Torres-Mendoza BM; Pérez-Ríos AM; González-Enriquez GV; Vázquez-Valls E
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319513
[TBL] [Abstract][Full Text] [Related]
6. Decreased recovery of replication-competent HIV-1 from peripheral blood mononuclear cell-derived monocyte/macrophages of HIV-positive patients after 3 years on highly active antiretroviral therapy.
Belmonte L; Baré P; Picchio GR; Perez Bianco R; de Tezanos Pinto M; Corti M; Villafañe MF; de Bracco MM; Ruibal-Ares BH
AIDS; 2002 Jun; 16(9):1289-92. PubMed ID: 12045497
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
Leeansyah E; Cameron PU; Solomon A; Tennakoon S; Velayudham P; Gouillou M; Spelman T; Hearps A; Fairley C; Smit de V; Pierce AB; Armishaw J; Crowe SM; Cooper DA; Koelsch KK; Liu JP; Chuah J; Lewin SR
J Infect Dis; 2013 Apr; 207(7):1157-65. PubMed ID: 23303810
[TBL] [Abstract][Full Text] [Related]
8. Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals.
Bukh AR; Melchjorsen J; Offersen R; Jensen JM; Toft L; Støvring H; Ostergaard L; Tolstrup M; Søgaard OS
PLoS One; 2011; 6(6):e21275. PubMed ID: 21731690
[TBL] [Abstract][Full Text] [Related]
9. Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.
Pasternak AO; Jurriaans S; Bakker M; Prins JM; Berkhout B; Lukashov VV
PLoS One; 2009 Dec; 4(12):e8490. PubMed ID: 20046870
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA.
Gianella S; Anderson CM; Vargas MV; Richman DD; Little SJ; Morris SR; Smith DM
J Infect Dis; 2013 Mar; 207(6):898-902. PubMed ID: 23275608
[TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
12. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M;
PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963
[TBL] [Abstract][Full Text] [Related]
13. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a miRNA profile in paediatric HIV-1 patients and its potential as a biomarker for effectiveness of the combined antiretroviral therapy.
Consuegra I; Gasco S; Serramía MJ; Jiménez JL; Mellado MJ; Muñoz-Fernández MÁ
Sci Rep; 2021 Dec; 11(1):23477. PubMed ID: 34873266
[TBL] [Abstract][Full Text] [Related]
15. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors.
Gruevska A; Moragrega AB; Galindo MJ; Esplugues JV; Blas-Garcia A; Apostolova N
Antiviral Res; 2020 Jun; 178():104784. PubMed ID: 32272174
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
[TBL] [Abstract][Full Text] [Related]
17. Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.
Brochado-Kith O; Martinez I; Berenguer J; Medrano LM; González-García J; Garcia-Broncano P; Jiménez-Sousa MÁ; Carrero A; Hontañón V; Muñoz-Fernández MÁ; Fernández-Rodríguez A; Resino S
AIDS; 2020 Nov; 34(13):1891-1897. PubMed ID: 32796212
[TBL] [Abstract][Full Text] [Related]
18. Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation.
Moreno S; Serrano-Villar S
EBioMedicine; 2016 Nov; 13():31-32. PubMed ID: 27765640
[No Abstract] [Full Text] [Related]
19. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
[TBL] [Abstract][Full Text] [Related]
20. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
